2m 2m 2m 2m 2m 2m 2m
Heron Therapeuti (HRTX)
NASDAQ
$0.35+$0.01 (+3.06%)
Price as of Aug 14, 2026 7:34 PM EDT- $63.9MMarket Cap
- -74.68%1-Year Change
- BiotechnologyIndustry
Heron Therapeuti (HRTX)
$0.35+$0.01 (+3.06%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 154.9M +7.36% | 144.3M +13.57% | 127.0M +17.99% | 107.7M +24.70% | |
Cost of Revenue | 41.3M +6.98% | 38.6M -40.64% | 65.1M +18.64% | 54.9M +19.24% | |
Gross Profit | 113.6M +7.50% | 105.6M +70.55% | 61.9M +17.31% | 52.8M +30.93% | |
Sales and Marketing Expense | 49.1M +4.20% | 47.1M -30.39% | 67.6M -18.02% | 82.5M -5.35% | |
Research and Development Expense | -12.4M -25.50% | -16.7M -70.15% | -55.9M -48.01% | -107.5M -17.82% | |
Depreciation and Amortization Expense | 2.3M -7.14% | 2.5M -14.04% | 2.9M +0.35% | 2.9M -4.37% | |
Total Operating Expenses | 116.1M -0.91% | 117.2M -32.10% | 172.6M -38.88% | 282.3M -7.18% | |
Operating Profit | -2.5M -77.98% | -11.5M -89.58% | -110.6M -36.67% | -174.7M -19.82% | |
Interest Income | 1.9M -45.13% | 3.5M +5.53% | 3.4M +105.37% | 1.6M +278.29% | |
Interest Expense | -7.1M +91.89% | -3.7M -4.34% | -3.9M +56.35% | -2.5M +2.66% | |
Interest Income and Expense and Net | -5.2M +3,334.67% | -150,000 -70.24% | -504,000 -39.71% | -836,000 -57.71% | |
Total Nonoperating Income and Expense | -17.7M +760.48% | -2.1M -3,764.29% | 56,000 +100.76% | -7.4M +158.00% | |
Income before Taxes | -2.5M -77.98% | -11.5M -89.58% | -110.6M -36.67% | -174.7M -19.82% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | 617,000 +195.22% | 209,000 -56.28% | |
Net Income | -20.2M +48.71% | -13.6M -87.72% | -110.6M -39.26% | -182.0M -17.52% | |
Net Income from Continuing Operations Applicable to Common | -20.2M +48.71% | -13.6M -87.72% | -110.6M -39.26% | -182.0M -17.52% | |
Basic EPS and Net Income | -0.12 +33.33% | -0.09 -88.75% | -0.80 -52.10% | -1.67 -25.45% | |
Diluted EPS and Net Income | -0.12 +33.33% | -0.09 -88.75% | -0.80 -52.10% | -1.67 -25.45% | |
Basic Weighted Average Shares | 166.7M +9.35% | 152.4M +10.36% | 138.1M +126,773.69% | 108,876 -99.89% | |
Diluted Weighted Average Shares | 166.7M +9.35% | 152.4M +10.36% | 138.1M +126,773.69% | 108,876 -99.89% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 28.6M +11.03% | 25.8M -10.03% | 28.7M +86.65% | 15.4M -83.03% | |
Short-Term Investments | 18.0M -46.29% | 33.5M -35.28% | 51.7M -25.55% | 69.5M +3.65% | |
Cash and Cash Equivalents and Short-Term Investments | 46.6M -21.34% | 59.3M -26.27% | 80.4M -5.24% | 84.9M -46.15% | |
Total Current Assets | 238.1M +13.90% | 209.0M +10.72% | 188.8M -8.11% | 205.4M -19.25% | |
Accumulated Depreciation | 12.9M -27.83% | 17.8M +4.81% | 17.0M +19.14% | 14.3M +7.93% | |
Property and Plant and Equipment and Net | 12.4M -16.55% | 14.9M -26.30% | 20.2M -9.00% | 22.2M -6.63% | |
Total Long-Term Assets | 5.4M -16.58% | 6.5M -20.24% | 8.1M -48.27% | 15.7M -11.34% | |
Total Assets | 255.9M +9.75% | 233.1M +4.78% | 222.5M -11.33% | 251.0M -17.91% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 96.1M +5.07% | 91.5M +14.77% | 79.7M -3.24% | 82.4M +15.90% | |
Total Long-Term Debt | 32.7M -78.13% | 149.7M +0.14% | 149.5M +0.14% | 149.3M +0.14% | |
Total Long-Term Liabilities | 4.8M +681.79% | 615,000 +155.19% | 241,000 0.00% | 241,000 -96.99% | |
Total Liabilities | 241.5M -9.47% | 266.8M +4.02% | 256.5M +8.05% | 237.4M +4.05% | |
Retained Earnings | -1.9B +1.05% | -1.9B +0.71% | -1.9B +6.16% | -1.8B +11.28% | |
Total Stockholders Equity | 14.3M +142.59% | -33.7M -0.95% | -34.0M -350.32% | 13.6M -82.50% | |
Total Shares Outstanding | 188.3M +23.79% | 152.1M +1.23% | 150.3M +26.13% | 119.2M +16.81% | |
Cash Flow | |||||
Cash from Operating Activities | -27.6M +22.47% | -22.5M -61.68% | -58.8M -59.98% | -146.9M -27.76% | |
Capital Expenditures | 317,000 -81.42% | 1.7M +10.42% | 1.5M -15.34% | 1.8M -39.61% | |
Cash from Investing Activities | 16.0M -14.45% | 18.7M +4.00% | 18.0M +641.37% | -3.3M -110.16% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 14.4M +1,434.79% | 940,000 -98.26% | 54.1M -27.91% | 75.1M -51.89% | |
Financials Ratio | |||||
Gross Margin | 73.31% +0.13% | 73.21% +50.17% | 48.75% -0.58% | 49.04% +5.00% | |
Operating Margin | -1.64% -79.49% | -7.99% -90.82% | -87.07% -46.32% | -162.21% -35.70% | |
Return on Assets | -8.26% +38.56% | -5.96% -87.24% | -46.70% -28.59% | -65.40% -2.31% | |
Return on Equity | 209.08% +420.57% | 40.16% -96.29% | 1,083.86% +371.35% | -399.43% +184.22% | |
Revenue Growth | 7.36% -45.77% | 13.57% -24.57% | 17.99% -27.15% | 24.70% +1,055.15% | |
Current Ratio | 2.48 +8.40% | 2.29 -3.53% | 2.37 -5.03% | 2.49 -30.33% | |
Cash Ratio | 0.30 +5.67% | 0.28 -21.62% | 0.36 +92.87% | 0.19 -85.36% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow